LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "dose gemcitabine" as a keyword



Continuous low‐dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study

Sign Up to like & get
recommendations! Published in 2022 at "Dermatologic Therapy"

DOI: 10.1111/dth.15482

Abstract: The aim of our retrospective study was to evaluate the efficacy of a continuous therapy with a lower dosage of gemcitabine compared to those usually administered in patients with cutaneous T cell lymphomas (CTCL). Twenty‐two… read more here.

Keywords: dose gemcitabine; retrospective study; gemcitabine; cutaneous cell ... See more keywords

Abstract B005: A phase 1 expansion cohort study evaluating the safety and efficacy of the CHK1 inhibitor LY2880070 with low-dose gemcitabine in metastatic pancreatic adenocarcinoma

Sign Up to like & get
recommendations! Published in 2024 at "Cancer Research"

DOI: 10.1158/1538-7445.panca2023-b005

Abstract: Background: Combining gemcitabine with CHK1 inhibition has shown promise in preclinical models of pancreatic ductal adenocarcinoma (PDAC). Here, we report the findings from a phase I expansion cohort study (NCT02632448) investigating low-dose gemcitabine combined with… read more here.

Keywords: dose gemcitabine; low dose; cohort; gemcitabine ... See more keywords

Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy

Sign Up to like & get
recommendations! Published in 2019 at "AntiCancer Research"

DOI: 10.21873/anticanres.13726

Abstract: Background/Aim: Gemcitabine is standard first-line treatment for patients with advanced pancreatic cancer, however the efficacy is limited. Although acquired drug resistance and side-effects are known to limit efficacy, opposite effects of a drug, which enhance… read more here.

Keywords: low dose; orthotopic; gemcitabine; metastasis ... See more keywords

R0 Resection for Locally Advanced Pancreatic Cancer with Low-dose Gemcitabine with Wide Irradiation Area as Neoadjuvant Chemoradiotherapy

Sign Up to like & get
recommendations! Published in 2018 at "In Vivo"

DOI: 10.21873/invivo.11362

Abstract: Background: Local antitumor efficacy and the outcome of neoadjuvant chemoradiotherapy (NACRT) with low-dose gemcitabine and wide irradiation area for borderline resectable and unresectable pancreatic cancer were evaluated. Patients and Methods: Thirty-four cases of borderline resectable… read more here.

Keywords: irradiation area; low dose; wide irradiation; pancreatic cancer ... See more keywords